Cassandra M. Pierre MD, MPH, MSc
Assistant Professor, Infectious Diseases
Medical Director of Public Health Programs , Infectious Diseases
771 Albany St | (617) 414-2894
Residency training: Boston Medical Center
Fellowship training: Boston Medical Center
Dr. Cassandra Pierre is an Assistant Professor at the Chobanian and Avedisian School of Medicine, the Medical Director of Public Health Programs and the Associate Hospital Epidemiologist at Boston Medical Center and the Chair of the Diversity and Inclusion Council. Supported by state and local public health agencies, the Public Health Programs provide resources for HIV, HCV and STI prevention, linkage to care and management throughout the hospital. Her research is focused on infection prevention in vulnerable population (including the implementation of low-cost infection control interventions to reduce bacteremia among neonates in low-income settings) Her clinical interests include HIV management in special subpopulations (immigrants of color, pregnant women, transactional sex workers and people with substance use).
MD, State University of New York at Buffalo, 2006
Global Health Management, MPH, Loma Linda University, 2005
English Literature, BA, Cornell University, 2001
Pepe DE, Mehrotra P, Bruno-Murtha LA, Colgrove R, Doron S, Duncan R, Ellison R, Haessler S, Hooper DC, Klompas M, Pierre CM, Sandora TJ, Shenoy ES, Wright SB. Use of expert consensus to develop a shared list of procedures with potential for aerosol generation during the coronavirus disease 2019 (COVID-19) pandemic. Antimicrob Steward Healthc Epidemiol. 2023; 3(1):e44. PMID: 36960085.Published on 3/6/2023
Pepe DE, Mehrotra P, Bruno-Murtha LA, Colgrove R, Doron S, Duncan R, Ellison R, Haessler S, Hooper DC, Klompas M, Pierre CM, Sandora TJ, Shenoy ES, Wright SB. Use of expert consensus to develop a shared list of procedures with potential for aerosol generation during the coronavirus disease 2019 (COVID-19) pandemic. Antimicrob Steward Healthc Epidemiol. 2023; 3(1):e44. PMID: 36960085.Published on 1/10/2023
Fletcher L, Burrowes SAB, Khan GK, Sabin L, Johnson S, Kimmel SD, Ruiz-Mercado G, Pierre C, Drainoni ML. Perspectives on long-acting injectable HIV antiretroviral therapy at an alternative care site: a qualitative study of people with HIV experiencing substance use and/or housing instability. Harm Reduct J. 2023 Jan 10; 20(1):4. PMID: 36627679.Published on 1/7/2023
Stewart J, Bartkus M, Sperring H, Ruiz-Mercado G, Johnson S, Pierre C. Monkeypox Vaccination Strategy and Missed Opportunities in STI and HIV Prevention: An Urban Sexual Health Clinic's Experience During a Public Health Emergency. Open Forum Infect Dis. 2023 Jan; 10(1):ofad006. PMID: 36726550.Published on 5/17/2022
Assoumou SA, Peterson A, Ginman E, James T, Pierre CM, Hamilton S, Chapman S, Goldie J, Koenig R, Mendez-Escobar E, Leaver H, Graham R, Crichlow R, Weaver T, Cotterell S, Valdez G, De Las Nueces D, Scott NA, Linas BP, Cherry PM. Addressing Inequities in SARS-CoV-2 Vaccine Uptake: The Boston Medical Center Health System Experience. Ann Intern Med. 2022 Jun; 175(6):879-884. PMID: 35576586.Published on 5/2/2022
Rowe SG, Stewart MT, Van Horne S, Pierre C, Wang H, Manukyan M, Bair-Merritt M, Lee-Parritz A, Rowe MP, Shanafelt T, Trockel M. Mistreatment Experiences, Protective Workplace Systems, and Occupational Distress in Physicians. JAMA Netw Open. 2022 May 02; 5(5):e2210768. PMID: 35522279.Published on 4/12/2022
Khan GK, Harvey L, Johnson S, Long P, Kimmel S, Pierre C, Drainoni ML. Integration of a community-based harm reduction program into a safety net hospital: a qualitative study. Harm Reduct J. 2022 Apr 12; 19(1):35. PMID: 35414072.Published on 9/17/2021
Bouton TC, Lodi S, Turcinovic J, Schaeffer B, Weber SE, Quinn E, Korn C, Steiner J, Schechter-Perkins EM, Duffy E, Ragan EJ, Taylor BP, Miller N, Davidoff R, Hanage WP, Connor J, Pierre C, Jacobson KR. Coronavirus Disease 2019 Vaccine Impact on Rates of Severe Acute Respiratory Syndrome Coronavirus 2 Cases and Postvaccination Strain Sequences Among Health Care Workers at an Urban Academic Medical Center: A Prospective Cohort Study. Open Forum Infect Dis. 2021 Oct; 8(10):ofab465. PMID: 34646910.Published on 5/6/2021
Kataria Y, Cole M, Duffy E, de la Cena K, Schechter-Perkins EM, Bouton TC, Werler MM, Pierre C, Ragan EJ, Weber SE, Jacobson KR, Andry C. Seroprevalence of SARS-CoV-2 IgG antibodies and risk factors in health care workers at an academic medical center in Boston, Massachusetts. Sci Rep. 2021 05 06; 11(1):9694. PMID: 33958668.Published on 4/27/2021
Burns RH, Pierre CM, Marathe JG, Ruiz-Mercado G, Taylor JL, Kimmel SD, Johnson SL, Fukuda HD, Assoumou SA. Partnering With State Health Departments to Address Injection-Related Infections During the Opioid Epidemic: Experience at a Safety Net Hospital. Open Forum Infect Dis. 2021 Aug; 8(8):ofab208. PMID: 34409120.
Published on 5/25/2023
Parade and event at City Hall mark Haitian Heritage month
Published on 5/21/2023
Face Mask Mandates Fall Away Among Many Hospitals, Doctors
Published on 5/11/2023
The COVID emergency is expiring in Massachusetts. What happens now?
Published on 5/10/2023
What the end of the COVID public health emergency means in Massachusetts
Published on 4/4/2023
What you should know about Candida auris and its presence in Massachusetts
Published on 1/26/2023
What infectious disease doctors want you to know as the COVID-19 pandemic enters its 4th year
Published on 1/24/2023
Deaths of Black, Hispanic and young Massachusetts residents rose in 2021
Published on 1/12/2023
Are we prepared for the next pandemic? Experts say no.
Published on 1/3/2023
The post-holiday COVID surge is here
Published on 12/30/2022
Here’s what to know about XBB, the new top COVID variant in the NortheastView full list of 218 media mentions.